Join the Oncology Voice Network. Join for Free
Demystifying and Unpacking Omnichannel Engagement
Omnichannel engagement Global Field Medical Excellence Organon Amgen MSLs strategies

Demystifying and Unpacking Omnichannel Engagement


Share This Article


Summary

In this week’s episode, Donnie Wooten, PharmD, Head of Global Field Medical Excellence at Organon and Kelly Lo, Global Field Medical Excellence at Amgen discuss the Demystifying and Unpacking of Omnichannel engagement.

Learn more about…

👉 How Omnichannel is currently being adopted and embraced
👉 What’s working and what’s going well with omnichannel strategies?
👉 What’s not going well, what are MSLs struggling with when it comes to Omnichannel
👉 The importance of executive buy in with Omnichannel
👉 Is Omnichannel living up to the hype

Click for Source
Omnichannel engagement, Global Field Medical Excellence, Organon, Amgen, MSLs strategies

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Podcast
Hiring Managers Beware: Reverse Rejection Explained!
Partner Avatar Michael Pietrack

Hiring Managers Beware: Reverse Rejection Explained!

Article
The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates
OVN Avatar Jamie Riley

The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Article
New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures
OVN Avatar Forbes Books Press Release Official

New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures

Podcast
MSL Career Options: The transition from Field Medical to Medical Director
Partner Avatar MSL Talk: Tom Caravela, Josh Corriveau

MSL Career Options: The transition from Field Medical to Medical Director

Explore OVN